Dave Gryska

Insider profile

Currently holds positions in Seagen Inc, PDL BioPharma Inc and Aerie Pharmaceuticals Inc

Performance

Overall performance
2.4

Performance over holding periods
2.4
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 46% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Independent Director Seagen Inc March 25, 2005 -
Independent Director PDL BioPharma Inc March 10, 2014 -
Independent Director Aerie Pharmaceuticals Inc Sept. 1, 2018 -
Chief Financial Officer, Executive Vice President Incyte Corp Oct. 31, 2014 - Dec. 31, 2018
Lead Independent Director Aerie Pharmaceuticals Inc Jan. 1, 2012 - May 15, 2015
Independent Director Argos Therapeutics Inc Jan. 1, 2012 - Oct. 31, 2014
Director Aerie Pharmaceuticals Inc None -

Dave Gryska's trades of Definium Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
191.43
Quantity 80,164 +41.8%
Value US$2,520,192
Transaction date
Purchase
Price
494.82
Quantity 1,813 +11.1%
Value US$2,756,790
Transaction date
Sale
Price
472.93
Quantity 76,424 -46.8%
Value US$2,690,861
Transaction date
Planned sale
Price
145.08
Quantity 690 -1.5%
Value US$100,105
Transaction date
Planned sale
Price
144.17
Quantity 1,516 -3.2%
Value US$218,562
Transaction date
Planned sale
Price
143.32
Quantity 1,794 -3.7%
Value US$257,116
Transaction date
Planned sale
Price
139.42
Quantity 2,371 -4.9%
Value US$330,565
Transaction date
Planned sale
Price
138.66
Quantity 1,029 -2.2%
Value US$142,681
Transaction date
Planned sale
Price
137.45
Quantity 1,100 -2.3%
Value US$151,195
Transaction date
Planned sale
Price
124.23
Quantity 214 -0.5%
Value US$26,585
Transaction date
Planned sale
Price
123.39
Quantity 883 -1.9%
Value US$108,953
Transaction date
Planned sale
Price
122.43
Quantity 2,553 -5.2%
Value US$312,564
Transaction date
Planned sale
Price
121.69
Quantity 850 -1.8%
Value US$103,436
Transaction date
Planned sale
Price
135.24
Quantity 4,500 -8.9%
Value US$608,581
Transaction date
Sale
Price
2.68
Quantity 75,000 -77.8%
Value US$201,000
Transaction date
Sale
Price
2.52
Quantity 75,000 -71.2%
Value US$189,000
Transaction date
Sale
Price
2.43
Quantity 50,000 -32.2%
Value US$121,500
Transaction date
Sale
Price
173.25
Quantity 7,871 -14.9%
Value US$1,363,651
Transaction date
Sale
Price
174.20
Quantity 7,129 -13.7%
Value US$1,241,872
Transaction date
Sale
Price
2.39
Quantity 50,000 -34.4%
Value US$119,500
Transaction date
Sale
Price
2.40
Quantity 100,000 -40.8%
Value US$240,000
Transaction date
Sale
Price
180.60
Quantity 4,500 -9.1%
Value US$812,699
Transaction date
Planned sale
Price
84.85
Quantity 2,500 -4.9%
Value US$212,125
Transaction date
Planned sale
Price
85.33
Quantity 2,500 -4.9%
Value US$213,325
Transaction date
Planned sale
Price
75.00
Quantity 5,000 -9.4%
Value US$375,000
Transaction date
Planned sale
Price
74.01
Quantity 206 -0.5%
Value US$15,246
Transaction date
Planned sale
Price
73.38
Quantity 4,794 -9.6%
Value US$351,784
Transaction date
Planned sale
Price
65.04
Quantity 5,000 -10.0%
Value US$325,200
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-05 2024-12-05 B Purchase
80,164 +41.8%
191.43
US$2,520,192
80,164 +41.8% 191.43 US$2,520,192
2024-08-26 2024-08-23 B Purchase
1,813 +11.1%
494.82
US$2,756,790
1,813 +11.1% 494.82 US$2,756,790
2022-11-15 2022-11-11 S Sale
76,424 -46.8%
472.93
US$2,690,861
76,424 -46.8% 472.93 US$2,690,861
2022-04-21 2022-04-19 PlS Planned sale
690 -1.5%
145.08
US$100,105
690 -1.5% 145.08 US$100,105
2022-04-21 2022-04-19 PlS Planned sale
1,516 -3.2%
144.17
US$218,562
1,516 -3.2% 144.17 US$218,562
2022-04-21 2022-04-19 PlS Planned sale
1,794 -3.7%
143.32
US$257,116
1,794 -3.7% 143.32 US$257,116
2022-02-09 2022-02-07 PlS Planned sale
2,371 -4.9%
139.42
US$330,565
2,371 -4.9% 139.42 US$330,565
2022-02-09 2022-02-07 PlS Planned sale
1,029 -2.2%
138.66
US$142,681
1,029 -2.2% 138.66 US$142,681
2022-02-09 2022-02-07 PlS Planned sale
1,100 -2.3%
137.45
US$151,195
1,100 -2.3% 137.45 US$151,195
2022-02-01 2022-01-28 PlS Planned sale
214 -0.5%
124.23
US$26,585
214 -0.5% 124.23 US$26,585
2022-02-01 2022-01-28 PlS Planned sale
883 -1.9%
123.39
US$108,953
883 -1.9% 123.39 US$108,953
2022-02-01 2022-01-28 PlS Planned sale
2,553 -5.2%
122.43
US$312,564
2,553 -5.2% 122.43 US$312,564
2022-02-01 2022-01-28 PlS Planned sale
850 -1.8%
121.69
US$103,436
850 -1.8% 121.69 US$103,436
2022-01-19 2022-01-14 PlS Planned sale
4,500 -8.9%
135.24
US$608,581
4,500 -8.9% 135.24 US$608,581
2020-12-17 2020-12-16 S Sale
75,000 -77.8%
2.68
US$201,000
75,000 -77.8% 2.68 US$201,000
2020-12-04 2020-12-03 S Sale
75,000 -71.2%
2.52
US$189,000
75,000 -71.2% 2.52 US$189,000
2020-11-24 2020-11-23 S Sale
50,000 -32.2%
2.43
US$121,500
50,000 -32.2% 2.43 US$121,500
2020-11-23 2020-11-19 S Sale
7,871 -14.9%
173.25
US$1,363,651
7,871 -14.9% 173.25 US$1,363,651
2020-11-23 2020-11-19 S Sale
7,129 -13.7%
174.20
US$1,241,872
7,129 -13.7% 174.20 US$1,241,872
2020-11-19 2020-11-18 S Sale
50,000 -34.4%
2.39
US$119,500
50,000 -34.4% 2.39 US$119,500
2020-11-19 2020-11-17 S Sale
100,000 -40.8%
2.40
US$240,000
100,000 -40.8% 2.40 US$240,000
2020-11-06 2020-11-05 S Sale
4,500 -9.1%
180.60
US$812,699
4,500 -9.1% 180.60 US$812,699
2019-10-03 2019-10-01 PlS Planned sale
2,500 -4.9%
84.85
US$212,125
2,500 -4.9% 84.85 US$212,125
2019-10-03 2019-10-01 PlS Planned sale
2,500 -4.9%
85.33
US$213,325
2,500 -4.9% 85.33 US$213,325
2019-07-19 2019-07-17 PlS Planned sale
5,000 -9.4%
75.00
US$375,000
5,000 -9.4% 75.00 US$375,000
2019-04-03 2019-04-01 PlS Planned sale
206 -0.5%
74.01
US$15,246
206 -0.5% 74.01 US$15,246
2019-04-03 2019-04-01 PlS Planned sale
4,794 -9.6%
73.38
US$351,784
4,794 -9.6% 73.38 US$351,784
2019-01-10 2019-01-08 PlS Planned sale
5,000 -10.0%
65.04
US$325,200
5,000 -10.0% 65.04 US$325,200